|
www.PicksThatMove.com: "Picks that move" Alerts, December 18, 2009: SENO, AIRV, SMOD, NEXM and CELG
(M2 PressWIRE Via Acquire Media NewsEdge) Picksthatmove.com Alerts include SenoRx, Inc. (Nasdaq:SENO); Airvana, Inc. (NASDAQ: AIRV); SMART Modular (NASDAQ: SMOD); NexMed, Inc. (Nasdaq: NEXM) and Celgene Corporation (Nasdaq:CELG)
-- December 18, 2009 SenoRx, Inc. (Nasdaq:SENO) trading at $6.51 on a volume of 242,494 shares
In a press release on December 18, SenoRx Found Not Liable for Patent Infringement
IRVINE, Calif., Dec 18, 2009 SenoRx, Inc. (Nasdaq:SENO) today announced that a jury delivered a verdict in favor of SenoRx in a lawsuit brought by Hologic, Inc., Cytyc Corp., and Hologic L.P. (Hologic) in the U.S. District Court for the Northern District of California. Hologic had alleged that SenoRx infringed claims of Hologic's 6,413,204 and 6,482,142 patents. SenoRx claimed that both patents were invalid, and that the '204 patent was not infringed.
About SenoRx
SenoRx (Nasdaq:SENO) develops, manufactures and sells minimally invasive medical devices used by breast care specialists for the diagnosis and treatment of breast cancer, including its EnCor(R) vacuum-assisted breast biopsy system and Contura(TM) MLB catheter for delivering radiation to the tissue surrounding the lumpectomy cavity following surgery for breast cancer. SenoRx's field sales organization serves over 2,000 breast diagnostic and treatment centers in the United States and Canada. In addition, SenoRx sells several of its products through distribution partners in more than 30 countries outside the U.S. and Canada. The company's line of breast care products includes biopsy disposables, biopsy capital equipment, diagnostic adjunct products and therapeutic disposables. SenoRx is developing additional minimally invasive products for the diagnosis and treatment of breast cancer. For more information, visit the company's website atwww.senorx.com.
-- December 18, 2009 Airvana, Inc. (NASDAQ: AIRV), trading at $7.52 on a volume of 6.98M shares
In a press release on December 18, Airvana, Inc. to be Acquired for Approximately $530 Million in Cash
Airvana Shareholders to Receive $7.65 per Share Representing 23% Premium;
CHELMSFORD, Mass., Dec 18, 2009 Company to Host Conference Call at 10:00 a.m. Today Airvana, Inc. (NASDAQ: AIRV), a leading provider of mobile broadband network infrastructure products, today announced that it has entered into a definitive agreement with a newly formed company to be owned by affiliates of S.A.C. Private Capital Group, LLC, GSO Capital Partners LP, Sankaty Advisors LLC and ZelnickMedia, in a transaction valued at approximately $530 million.
About Airvana, Inc.
Airvana helps operators transform the mobile experience for users worldwide. Airvana, Inc.'s high-performance technology and products, from comprehensive femtocell solutions to core mobile network infrastructure, enable operators to deliver compelling and consistent broadband services to mobile subscribers, wherever they are. Airvana, Inc.'s products are deployed in over 70 commercial networks on six continents. Airvana, Inc. is headquartered in Chelmsford, Mass., USA, with offices worldwide. For more information, please visit www.airvana.com.
-- December 18, 2009 SMART Modular (NASDAQ: SMOD) trading at $6.02 on a volume of 2.03M shares.
In a press release out on December 18, Former Seagate Storage Executive Joins SMART Modular Technologies' Executive Team
John Scaramuzzo to Focus on Driving SMART's Solid State Storage Business
NEWARK, CA, Dec 18, 2009 SMART Modular Technologies (WWH), Inc. ("SMART" or the "Company") (NASDAQ: SMOD), a leading independent manufacturer of memory modules and solid state storage products including SSDs, announced the appointment of John Scaramuzzo as SMART's Senior Vice President and General Manager, Storage Business Unit. Mr. Scaramuzzo's appointment will be effective on January 4, 2010, and he will report directly to Iain MacKenzie, SMART's President and CEO. John's key areas of responsibilities will include all of SMART's storage business in the enterprise, industrial, defense and aerospace sectors.
About SMART
SMART is a leading independent designer, manufacturer and supplier of electronic subsystems to original equipment manufacturers, or OEMs. SMART offers more than 500 standard and custom products to OEMs engaged in the computer, industrial, networking, telecommunications aerospace, and defense markets. Taking innovations from the design stage through manufacturing and delivery, SMART has developed a comprehensive memory product line that includes DRAM, SRAM, and Flash memory in various form factors. SMART also offers high performance, high capacity SSDs for enterprise, defense, aerospace, industrial automation, medical, and transportation markets. SMART's presence in the U.S., Europe, Asia, and Latin America enables it to provide its customers with proven expertise in international logistics, asset management, and supply-chain management worldwide. See www.smartm.com for more information.
-- December 18, 2009 NexMed, Inc. (Nasdaq: NEXM) trading at $0.369 on a volume of 4.76M shares.
In a press release out on December 18, NexMed Granted Continued Listing on NASDAQ
NexMed must evidence minimum stockholders' equity of $2.5 million or minimum market capitalization of $35 million by March 31, 2010
EAST WINDSOR, N.J., Dec 18, 2009 NexMed, Inc. (Nasdaq: NEXM), a specialty CRO and a developer of products based on the NexACT(R) technology, today announced that it received a letter from the NASDAQ Listing Qualifications Panel (the "Panel") on December 17, 2009, informing the Company that the Panel had granted the Company's request to remain listed on the NASDAQ Stock Market, subject to the condition that, on or before March 31, 2010, the Company evidence stockholders' equity of at least $2.5 million or a market value of listed securities of at least $35 million, which are the applicable minimum requirements for the continued listing of the Company's securities on The NASDAQ Capital Market.
About NexMed
NexMed, due to its recent acquisition of Bio-Quant, is the largest specialty contract research organization ("CRO") based in San Diego, CA and is one of the industry's most experienced CROs for in vitro and in vivo pharmacology services and research models. NexMed is also developing a proprietary product pipeline based on its NexACT(R) drug delivery technology, including a late stage terbinafine treatment for onychomycosis, a late stage alprostadil treatment for erectile dysfunction, a Phase 2 alprostadil treatment for female sexual arousal disorder and an early stage treatment for psoriasis. For further information, go towww.nexmed.com and www.bio-quant.com.
-- December 18, 2009 Celgene Corporation (Nasdaq:CELG) last at $56.01 on a volume of 6.28M shares
In a press release out on December 17, Initial Data from CALGB-Led Study of Treatment with Continuous REVLIMID(R) in Patients with Multiple Myeloma Following Autologous Stem Cell Transplant Reported
Study showed statistically significant improvement in time to disease progression
SUMMIT, N.J., Dec 18, 2009 Celgene Corporation (Nasdaq:CELG) today announced the National Cancer Institute (NCI), a part of the National Institutes of Health, reported initial data from a Phase III, randomized, double-blind, multi-center clinical study led by the Cancer and Leukemia Group B (CALGB). The investigational study evaluated REVLIMID(R) compared to placebo in multiple myeloma patients following autologous stem cell transplant, and the independent Data and Safety Monitoring Board reported that the trial had met its primary endpoint of a statistically significant improvement in time to disease progression. The study was sponsored by the NCI under a Clinical Trials Agreement with Celgene.
About Celgene Corporation
Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of novel therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. For more information, please visit the company's Web site at www.celgene.com.
www.picksthatmove.com is a leading stock website that provides free daily alerts on stocks that are moving up. www.picksthatmove.com also tracks small cap stocks that are on the brink of exploding. We also feature companies on our website with research report, analysis, and newsletters. To feature a company on our web site please contact us at Info@picksthatmove.com
www.picksthatmove.com is an independent electronic publication that provides information on selected publicly traded companies. www.picksthatmove.com is not a registered investment advisor or broker-dealer. www.picksthatmove.com affiliates, officers, directors and employees may buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise in value. Please do your own Due Diligence before investing in any of the stocks mentioned above.
((Comments on this story may be sent to info@m2.com))
(c) 2009 M2 COMMUNICATIONS
[ Back To Homepage ]
|
Home
Featured Article Archives
eNews
RSS FEED
